PJP vs. XLV
PJP (Invesco Dynamic Pharmaceuticals ETF) and XLV (State Street Health Care Select Sector SPDR ETF) are both Health & Biotech Equities funds - PJP tracks the Dynamic Pharmaceuticals Intellidex Index while XLV tracks the Health Care Select Sector Index. Both are passively managed. Over the past 10 years, PJP returned 6.15%/yr vs 9.20%/yr for XLV. Their correlation of 0.83 suggests significant overlap in exposure. PJP charges 0.58%/yr vs 0.08%/yr for XLV.
Performance
PJP vs. XLV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PJP achieves a 2.90% return, which is significantly higher than XLV's -4.29% return. Over the past 10 years, PJP has underperformed XLV with an annualized return of 6.15%, while XLV has yielded a comparatively higher 9.20% annualized return.
PJP
- 1D
- 1.20%
- 1M
- 1.29%
- YTD
- 2.90%
- 6M
- 2.29%
- 1Y
- 34.73%
- 3Y*
- 13.31%
- 5Y*
- 7.62%
- 10Y*
- 6.15%
XLV
- 1D
- 0.79%
- 1M
- 1.95%
- YTD
- -4.29%
- 6M
- -4.06%
- 1Y
- 12.89%
- 3Y*
- 5.98%
- 5Y*
- 5.55%
- 10Y*
- 9.20%
PJP vs. XLV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PJP Invesco Dynamic Pharmaceuticals ETF | 2.90% | 27.98% | 9.63% | -2.18% | -2.16% | 14.58% | 11.29% | 4.64% | -1.78% | 15.30% |
XLV State Street Health Care Select Sector SPDR ETF | -4.29% | 14.50% | 2.47% | 2.07% | -2.08% | 26.04% | 13.30% | 20.45% | 6.28% | 21.77% |
Correlation
The correlation between PJP and XLV is 0.78, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.78 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.77 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.79 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.80 |
Correlation (All Time) Calculated using the full available price history since Jun 24, 2005 | 0.83 |
The correlation between PJP and XLV has been stable across timeframes, ranging from 0.77 to 0.83 - a consistent structural relationship.
PJP vs. XLV - Sectors Allocation Comparison
Sectors
PJP
XLV
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
PJP
XLV
Basic Materials
PJP
-
XLV
-
Communication Services
PJP
-
XLV
-
Consumer Cyclical
PJP
-
XLV
-
Consumer Defensive
PJP
-
XLV
-
Energy
PJP
-
XLV
-
Financial Services
PJP
-
XLV
-
Industrials
PJP
-
XLV
-
Real Estate
PJP
-
XLV
-
Technology
PJP
-
XLV
-
Utilities
PJP
-
XLV
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PJP vs. XLV — Risk / Return Rank
PJP
XLV
PJP vs. XLV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Pharmaceuticals ETF (PJP) and State Street Health Care Select Sector SPDR ETF (XLV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PJP | XLV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.25 | ||
| Sortino ratioReturn per unit of downside risk | +1.59 | ||
| Omega ratioGain probability vs. loss probability | 1.36 | 1.16 | +0.20 |
| Calmar ratioReturn relative to maximum drawdown | 3.70 | 1.24 | +2.46 |
| Martin ratioReturn relative to average drawdown | 11.55 | 2.99 | +8.56 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PJP | XLV | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.13 | 0.88 | +1.25 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.47 | 0.38 | +0.09 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.34 | 0.56 | -0.22 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.59 | 0.46 | +0.13 |
Drawdowns
PJP vs. XLV - Drawdown Comparison
The maximum PJP drawdown since its inception was -37.06%, smaller than the maximum XLV drawdown of -39.17%. Use the drawdown chart below to compare losses from any high point for PJP and XLV.
Loading charts...
Drawdown Indicators
| PJP | XLV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -37.06% | -39.17% | +2.11% |
Max Drawdown (1Y)Largest decline over 1 year | -9.44% | -10.47% | +1.03% |
Max Drawdown (3Y)Largest decline over 3 years | -16.27% | -17.11% | +0.84% |
Max Drawdown (5Y)Largest decline over 5 years | -17.51% | -17.11% | -0.40% |
Max Drawdown (10Y)Largest decline over 10 years | -33.95% | -28.40% | -5.55% |
Current DrawdownCurrent decline from peak | -2.94% | -7.52% | +4.58% |
Average DrawdownAverage peak-to-trough decline | -8.85% | -7.12% | -1.73% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.02% | 4.32% | -1.30% |
Volatility
PJP vs. XLV - Volatility Comparison
Invesco Dynamic Pharmaceuticals ETF (PJP) has a higher volatility of 5.33% compared to State Street Health Care Select Sector SPDR ETF (XLV) at 4.10%. This indicates that PJP's price experiences larger fluctuations and is considered to be riskier than XLV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PJP | XLV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.33% | 4.10% | +1.23% |
Volatility (6M)Calculated over the trailing 6-month period | 12.02% | 10.24% | +1.78% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.38% | 14.67% | +1.71% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.17% | 14.69% | +1.48% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.39% | 16.55% | +1.84% |
PJP vs. XLV - Expense Ratio Comparison
PJP has a 0.58% expense ratio, which is higher than XLV's 0.08% expense ratio.
Dividends
PJP vs. XLV - Dividend Comparison
PJP's dividend yield for the trailing twelve months is around 0.99%, less than XLV's 1.70% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PJP Invesco Dynamic Pharmaceuticals ETF | 0.99% | 0.98% | 0.97% | 1.01% | 0.95% | 0.81% | 0.75% | 0.77% | 1.12% | 0.65% | 0.91% | 5.49% |
XLV State Street Health Care Select Sector SPDR ETF | 1.70% | 1.60% | 1.67% | 1.59% | 1.47% | 1.33% | 1.49% | 2.17% | 1.57% | 1.47% | 1.60% | 1.43% |
Frequently Asked Questions
PJP and XLV have a correlation of 0.78, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PJP has higher volatility (5.33%) compared to XLV (4.10%). In terms of maximum drawdown, PJP dropped -37.06% vs XLV's -39.17%.
On 10-year performance, XLV leads with 9.20% vs 6.15% for PJP. On fees, XLV is cheaper at 0.08% per year. On volatility, XLV has been the lower-risk option at 4.10%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, XLV has performed better with a 9.20% return vs 6.15%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XLV is cheaper with a 0.08% expense ratio, compared with 0.58% for PJP.
XLV has the higher dividend yield at 1.70%, compared with 0.99% for PJP.
PJP tracks Dynamic Pharmaceuticals Intellidex Index, while XLV tracks Health Care Select Sector Index. They also come from different issuers: Invesco and State Street. Their fees differ too: 0.58% for PJP and 0.08% for XLV.
PJP currently has the higher Sharpe Ratio (2.13 vs 0.88), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PJP and XLV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer